AURKB activates EMT through PI3K/AKT signaling axis to promote ICC progression

被引:9
|
作者
Ma, Peng [1 ]
Hao, Ying [1 ]
Wang, Wei [1 ]
Zhang, Yue-Feng [1 ]
Yu, Kai-Huan [1 ]
Wang, Wei-Xing [1 ]
机构
[1] Wuhan Univ, Renmin Hosp, Dept Hepatobiliary Surg, Wuhan 430060, Hubei, Peoples R China
关键词
EPITHELIAL-MESENCHYMAL TRANSITION; CHOLANGIOCARCINOMA; SURVIVAL;
D O I
10.1007/s12672-023-00707-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Intrahepatic cholangiocarcinoma (ICC) is a fatal disease and the molecular mechanism of its progression remains unknown. Aurora Kinase B (AURKB) is a central regulator of chromosome separation and cytokinesis and is abnormally expressed in a variety of cancer cells. This research aimed to explore the effect of AURKB in occurrence and metastasis of ICC. We found that AURKB showed a progressive up-regulation pattern from normal bile duct tissue to ICC with high invasion. Our data showed that AURKB significantly promoted ICC cell proliferation, induced epithelial-mesenchymal transition (EMT), migration and invasion through gain- and loss- of function experiments. In vivo results consistently showed that AURKB up-regulation not only promoted tumor growth, but also promoted tumor metastasis. Importantly, we discovered that AURKB regulates the expressions of EMT-related genes via PI3K/AKT signaling axis. Herein, our results suggest that AURKB induced EMT through the activation of PI3K/AKT signaling pathway is critical to the progression of ICC, which may be a prospective therapeutic treatment for overcoming ICC metastasis and progression.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] AURKB activates EMT through PI3K/AKT signaling axis to promote ICC progression
    Peng Ma
    Ying Hao
    Wei Wang
    Yue-Feng Zhang
    Kai-Huan Yu
    Wei-Xing Wang
    Discover Oncology, 14
  • [2] A PLCB1-PI3K-AKT Signaling Axis Activates EMT to Promote Cholangiocarcinoma Progression
    Liang, Shuhang
    Guo, Hongrui
    Ma, Kun
    Li, Xianying
    Wu, Dehai
    Wang, Yiqi
    Wang, Wei
    Zhang, Shugeng
    Cui, Yifeng
    Liu, Yufeng
    Sun, Linmao
    Zhang, Bo
    Xin, Mengyang
    Zhang, Ning
    Zhou, Huanran
    Liu, Yao
    Wang, Jiabei
    Liu, Lianxin
    CANCER RESEARCH, 2021, 81 (23) : 5889 - 5903
  • [3] YY1 activates EMI2 and promotes the progression of cholangiocarcinoma through the PI3K/Akt signaling axis
    Shuai Zhou
    Kang Lin Qu
    Jin Ang Li
    Shi Lei Chen
    Yi Gang Zhang
    Chao Zhu
    Hao Jin
    Yong Wang
    Qing Pang
    Hui Chun Liu
    Cancer Cell International, 21
  • [4] YY1 activates EMI2 and promotes the progression of cholangiocarcinoma through the PI3K/Akt signaling axis
    Zhou, Shuai
    Qu, Kang Lin
    Li, Jin Ang
    Chen, Shi Lei
    Zhang, Yi Gang
    Zhu, Chao
    Jin, Hao
    Wang, Yong
    Pang, Qing
    Liu, Hui Chun
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [5] AURKB targets DHX9 to promote hepatocellular carcinoma progression via PI3K/AKT/mTOR pathway
    Zhu, Guoqing
    Luo, Laihui
    He, Yongzhu
    Xiao, Yongqiang
    Cai, Ziwei
    Tong, Weilai
    Deng, Wei
    Xie, Jin
    Zhong, Yanxin
    Hu, Zhigao
    Shan, Renfeng
    MOLECULAR CARCINOGENESIS, 2024, 63 (09) : 1814 - 1826
  • [6] SOX9/miR-203a axis drives PI3K/AKT signaling to promote esophageal cancer progression
    Wang, Lianghai
    Zhang, Zhiyu
    Yu, Xiaodan
    Li, Qihang
    Wang, Qian
    Chang, Aimin
    Huang, Xiaoxi
    Han, Xueping
    Song, Yangguang
    Hu, Jianming
    Pang, Lijuan
    Hou, Jun
    Li, Feng
    CANCER LETTERS, 2020, 468 : 14 - 26
  • [7] Endothelial Progenitor Cells Promote Osteosarcoma Progression and Invasiveness via AKT/PI3K Signaling
    Doppelt-Flikshtain, Ofri
    Younis, Amin
    Tamari, Tal
    Ginesin, Ofir
    Shentzer-Kutiel, Talia
    Nikomarov, David
    Bar-Sela, Gil
    Coyac, Benjamin R.
    Assaraf, Yehuda G.
    Zigdon-Giladi, Hadar
    CANCERS, 2023, 15 (06)
  • [8] SOX9/miR-203a axis drives PI3K/AKT/mTOR signaling to promote esophageal cancer progression
    Wang, L.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1556 - 1556
  • [9] Hypermethylation of DLG3 Promoter Upregulates RAC1 and Activates the PI3K/AKT Signaling Pathway to Promote Breast Cancer Progression
    Liu, Bingbing
    Xu, Yanning
    Zhang, Lin
    Yang, Xue
    Chen, Ling
    Liu, Yixin
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [10] Interleukin-4 activates the PI3K/AKT signaling to promote apoptosis and inhibit the proliferation of granulosa cells
    Han, Ying
    Yao, Ruqiang
    Yang, Zexin
    Li, Shuang
    Meng, Wenjia
    Zhang, Yinfeng
    Zhang, Yunshan
    Luo, Haining
    EXPERIMENTAL CELL RESEARCH, 2022, 412 (01)